F510-0521 Screening compound: N,N-diethyl-3-oxo-4-{2-oxo-2-[4-(pyridin-2-yl)piperazin-1-yl]ethyl}-3,4-dihydro-2H-1,4-benzothiazine-6-carboxamide

F510-0521 Screening compound: N,N-diethyl-3-oxo-4-{2-oxo-2-[4-(pyridin-2-yl)piperazin-1-yl]ethyl}-3,4-dihydro-2H-1,4-benzothiazine-6-carboxamide
F510-0521 Screening compound: N,N-diethyl-3-oxo-4-{2-oxo-2-[4-(pyridin-2-yl)piperazin-1-yl]ethyl}-3,4-dihydro-2H-1,4-benzothiazine-6-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F510-0521
N,N-diethyl-3-oxo-4-{2-oxo-2-[4-(pyridin-2-yl)piperazin-1-yl]ethyl}-3,4-dihydro-2H-1,4-benzothiazine-6-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F510-0521

Molecular Formula

C24H29N5O3S (C24 H29 N5 O3 S)

Compound Name

N,N-diethyl-3-oxo-4-{2-oxo-2-[4-(pyridin-2-yl)piperazin-1-yl]ethyl}-3,4-dihydro-2H-1,4-benzothiazine-6-carboxamide

IUPAC name

NN-diethyl-3-oxo-4-{2-oxo-2-[4-(pyridin-2-yl)piperazin-1-yl]ethyl}-34-dihydro-2H-14-benzothiazine-6-carboxamide

SMILES

CCN(CC)C(c(cc1)cc(N2CC(N(CC3)CCN3c3ncccc3)=O)c1SCC2=O)=O

InChI

InChI=1S/C24H29N5O3S/c1-3-26(4-2)24(32)18-8-9-20-19(15-18)29(23(31)17-33-20)16-22(30)28-13-11-27(12-14-28)21-7-5-6-10-25-21/h5-10,15H,3-4,11-14,16-17H2,1-2H3

InChI Key

NCLMJBABNCKYBP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27170496

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

467.59

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.589

Distribution Coefficient, logD

1.580

Water Solubility, LogSw

-2.35

Polar Surface Area

59.715

Acid Dissociation Constant (pKa)

20.50

Base Dissociation Constant (pKb)

5.71

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

41.70

F510-0521 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

SmartTM Library (51161 compounds)

Akt-Targeted Library (14764 compounds)

Epigenetics Focused Set (26518 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with F510-0521 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F510-0521?
Check Price and Availability of F510-0521, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F510-0521 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F510-0521
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F510-0521
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F510-0521 available by request